BackAdvaxis Overview

Advaxis Profit Margin

Latest profit margin for Advaxis: -369784.62% — see history and peer comparisons.

Get informed when a big investor buys or sells

+ Follow

Quarterly Profit Margin

N/A

As of Dec 2023

Annual Profit Margin (TTM)

-369784.62%
9963.55% YoY

Trailing 12 months ending Dec 2023

Average Profit Margin (Comparison Companies)

Loading

Profit Margin History

Loading

Profit Margin Comparison

Loading

Annual Profit Margin Growth Rate (%)

Loading

Advaxis (ADXS) FAQ

Advaxis (ADXS) currently reports a profit margin of -369784.62% as of December 2023. That compares with -3674.49% in the prior-year period — down 9963.6% year over year. That is below the Healthcare sector average of 14.34%. Use the charts on this page to explore Advaxis's profit margin history and peer comparisons.

Advaxis's profit margin decreased from -3674.49% to -369784.62% — a 9963.6% year-over-year decrease (period ending December 2023). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Advaxis's profit margin of -369784.62% is lower than the Healthcare sector average of 14.34%. That is roughly 2577933.9% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' profit margin, but Advaxis's current -369784.62% should be judged against Healthcare norms (sector average: 14.34%) and against ADXS's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current profit margin of -369784.62%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 14.34%. From there, open related valuation or income-statement pages for Advaxis, and consider following ADXS for alerts when major investors trade the stock.